8-K: SeaStar Medical Approves 1-for-10 Reverse Stock Split

SeaStar Medical Holding Corporation's shareholders approved a 1-for-10 reverse stock split and a reduction in authorized shares at a special meeting on December 18, 2025.

Summary

• Shareholders of SeaStar Medical Holding Corporation approved a 1-for-10 reverse stock split at a special meeting held on December 18, 2025.
• The reverse split will become effective at 12:01 AM Eastern Standard Time on January 2, 2026, with shares trading on a split-adjusted basis on the Nasdaq Capital Market under the symbol "ICU" on the same date.
• All outstanding stock options and warrants of the Company will be proportionally adjusted following the reverse split.
• Fractional shares resulting from the reverse split will not be issued; instead, the number of shares will be rounded up to the next whole number.
• Immediately after the reverse split, there will be approximately 3.8 million shares of common stock issued and outstanding.
• Shareholders also approved an amendment to reduce the authorized number of common stock shares by 25,000,000, setting the new total at 425,000,000.

Sentiment

Score: 4

Explanation: The filing reports the successful shareholder approval of a reverse stock split and a reduction in authorized shares. While the approval itself is a procedural positive, reverse stock splits are often indicative of a low share price, which can be perceived negatively by the market, suggesting underlying challenges.

Positives

• Shareholders approved the 1-for-10 reverse stock split, indicating support for the Board's strategic decision.
• Shareholders approved the reduction of authorized common stock by 25,000,000 shares to 425,000,000, which can limit potential future dilution.
• The reverse split will not modify the rights or preferences of the common stock.
• Fractional shares will be rounded up to the next whole number, benefiting shareholders who would otherwise receive fractional shares.

Future Outlook

The 1-for-10 reverse stock split will be effective as of 12:01 AM Eastern Standard Time on January 2, 2026, with shares of common stock beginning to trade on a split-adjusted basis on the Nasdaq Capital Market on the same date under the symbol "ICU".

Industry Context

Reverse stock splits are a common corporate action often undertaken by companies with low share prices to meet exchange listing requirements, improve market perception, or make the stock more attractive to institutional investors. This action by SeaStar Medical aligns with such common industry practices for companies seeking to maintain or enhance their market standing.

Comparison to Industry Standards

• Reverse stock splits are a common mechanism for companies to address low share prices and maintain listing compliance on major exchanges like Nasdaq.
• Many companies across various sectors, particularly those in growth-oriented or early-stage industries, have historically utilized reverse splits to improve their stock's marketability and meet minimum price requirements.

Corporate Governance

Stakeholder Impact

• Shareholders: Their number of shares will be reduced by a 1-for-10 ratio, but the proportional value of their holdings should remain the same initially. Fractional shares will be rounded up.
• Investors: The reverse split may impact market perception and liquidity, potentially making the stock more attractive to institutional investors due to a higher per-share price.
• Employees (holding options/warrants): Stock options and warrants will be proportionally adjusted to reflect the reverse split.

Next Steps

• The 1-for-10 reverse stock split will become effective at 12:01 AM Eastern Standard Time on January 2, 2026.
• Shares of common stock will begin trading on a split-adjusted basis on the Nasdaq Capital Market on January 2, 2026.
• Continental Stock Transfer and Trust Company, Inc. will act as the exchange agent for the reverse stock split.

Key Dates

Keywords

SeaStar Medical, Reverse Stock Split, Shareholder Meeting, Nasdaq, Common Stock, Authorized Shares, ICU, Corporate Governance